Soleno Therapeutics Inc at Destiny-PWS Transcript
Welcome, everyone, to today's presentation. I love how those of you who have been joining us on previous sessions today recognize that the music was not playing on that video. I love listening to that video. Every time I watch it, it almost brings tears to my eyes because it reminds me of how much our community and our kids are working together to find treatments for PWS. And that's why I'm so thrilled to have today's presentation, which is a return of results presentation.
So to kick off today's session, I would like to present to you, Anish Bhatnagar, CEO of Soleno Therapeutics.
Thank you, Susan. My name is Anish Bhatnagar. I'm the CEO of Soleno Therapeutics. Also one of the physicians involved in the DCCR development program at the company. I'm really thankful to FPWR for giving us the opportunity to speak here today. And also, shoutout to Susan for the amazing job she's doing keeping this train running. It's a challenging time with all of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |